Pharmaceutical Industry

Pharmaceutical Industry

The Pursuit of Purity, Safety, and Innovation

India supplies a large share of the world’s generic medicines and is a major source of active pharmaceutical ingredients. With stricter GMP expectations, revised Schedule M requirements and regular audits by global regulators, quality and contamination control sit at the heart of the industry’s growth.

Powder handling, granulation, milling, blending, coating and solvent-based processes release fine dust, volatile organic compounds and potent compound residues. These pose risks to operator health, product purity and the environment. Bulk drug and API units also generate solvent vapours and acidic or alkaline fumes from reactions and distillation. As more highly potent and complex molecules enter production, containment and the treatment of process and vent emissions are receiving greater attention.